AstraZeneca reprimanded over LinkedIn likes once again
The LinkedIn activities of AstraZeneca employees have yet again landed the drugmaker in hot water, with the U.K. The LinkedIn activities of AstraZeneca employees have yet again landed the drugmaker in hot water, with the U.K. marketing watchdog identifying eight breaches of its rules in the latest of a series of cases. Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Special Report Awards Gala Trending Oncology Supply Chain AI and Machine Learning Awards Outsourcing Awards Innovation Awards Pharma Marketing Awards Resources Podcasts Fierce Events Industry Events Webinars…

The LinkedIn activities of AstraZeneca employees have yet again landed the drugmaker in hot water, with the U.K. marketing watchdog identifying eight breaches of its rules in the latest of a series of cases.
Source: FiercePharma